Aicardi–Goutières syndrome: a model disease for systemic autoimmunity
暂无分享,去创建一个
[1] M. Benkirane,et al. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. , 2013, Cell reports.
[2] Baek Kim,et al. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. , 2013, Cell host & microbe.
[3] K. Fitzgerald,et al. Molecular Basis of DNA Recognition in the Immune System , 2013, The Journal of Immunology.
[4] Zhijian J. Chen,et al. Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.
[5] P. Schwille,et al. Single-stranded nucleic acids promote SAMHD1 complex formation , 2013, Journal of Molecular Medicine.
[6] B. Nocek,et al. Nuclease Activity of the Human SAMHD1 Protein Implicated in the Aicardi-Goutières Syndrome and HIV-1 Restriction* , 2013, The Journal of Biological Chemistry.
[7] L. Quintanilla‐Martinez,et al. Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. , 2012, Immunity.
[8] Nan Yan,et al. Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes , 2012, Nature Immunology.
[9] Annette Lee,et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B cell signaling and activation , 2012, Nature Genetics.
[10] L. Alexopoulou,et al. Resurrection of endogenous retroviruses in antibody-deficient mice , 2012, Nature.
[11] T. Kunkel,et al. RNase H2-initiated ribonucleotide excision repair. , 2012, Molecular cell.
[12] John H Livingston,et al. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature , 2012, Nature Genetics.
[13] R. Naumann,et al. Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity , 2012, The Journal of experimental medicine.
[14] R. Silver,et al. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi–Goutières syndrome , 2012, The British journal of dermatology.
[15] G. Superti-Furga,et al. SAMHD1 is a nucleic‐acid binding protein that is mislocalized due to aicardi–goutières syndrome‐associated mutations , 2012, Human mutation.
[16] D. C. Hancks,et al. Active human retrotransposons: variation and disease. , 2012, Current opinion in genetics & development.
[17] Martin A. M. Reijns,et al. Enzymatic Removal of Ribonucleotides from DNA Is Essential for Mammalian Genome Integrity and Development , 2012, Cell.
[18] R. Furie,et al. Belimumab Is Approved by the FDA: What More Do We Need to Know to Optimize Decision Making? , 2012, Current Rheumatology Reports.
[19] Baek Kim,et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates , 2012, Nature Immunology.
[20] D. Stetson,et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. , 2012, Immunity.
[21] M. Wabl,et al. An autoimmune disease prevented by anti-retroviral drugs , 2011, Retrovirology.
[22] Geoff Kelly,et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase , 2011, Nature.
[23] H. Khalak,et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus , 2011, Nature Genetics.
[24] Qingde Wang,et al. RNA editing catalyzed by ADAR1 and its function in mammalian cells , 2011, Biochemistry (Moscow).
[25] B. Sobhian,et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.
[26] M. Washburn,et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.
[27] Y. Pommier,et al. Mutagenic Processing of Ribonucleotides in DNA by Yeast Topoisomerase I , 2011, Science.
[28] C D Langefeld,et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort , 2011, Genes and Immunity.
[29] C. Samuel,et al. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. , 2011, Virology.
[30] Martin A. M. Reijns,et al. PCNA directs type 2 RNase H activity on DNA replication and repair substrates , 2011, Nucleic acids research.
[31] Y. Crow,et al. Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus , 2011, American journal of medical genetics. Part A.
[32] D. Wallace. Advances in drug therapy for systemic lupus erythematosus , 2010, BMC medicine.
[33] M. Crow,et al. Activation of the type I interferon pathway in primary Sjogren's syndrome. , 2010, Journal of autoimmunity.
[34] Y. Crow,et al. A de novo p.Asp18Asn mutation in TREX1 in a patient with Aicardi–Goutières syndrome , 2010, American journal of medical genetics. Part A.
[35] S. Kamphuis,et al. Prevalence and burden of pediatric-onset systemic lupus erythematosus , 2010, Nature Reviews Rheumatology.
[36] Danielle L. Watt,et al. Genome instability due to ribonucleotide incorporation into DNA , 2010, Nature chemical biology.
[37] L. Morel. Genetics of SLE: evidence from mouse models , 2010, Nature Reviews Rheumatology.
[38] L. Rönnblom,et al. Type I interferon system activation and association with disease manifestations in systemic sclerosis , 2010, Annals of the rheumatic diseases.
[39] Andrew C. Chan,et al. Therapeutic antibodies for autoimmunity and inflammation , 2010, Nature Reviews Immunology.
[40] D. Wieczorek,et al. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. , 2010, Arthritis and rheumatism.
[41] V. Hornung,et al. Intracellular DNA recognition , 2010, Nature Reviews Immunology.
[42] M. Ferrari,et al. TREX1 gene variant in neuropsychiatric systemic lupus erythematosus , 2009, Annals of the rheumatic diseases.
[43] L. Rönnblom,et al. Type I interferon and lupus , 2009, Current opinion in rheumatology.
[44] Jonathan C. Fuller,et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response , 2009, Nature Genetics.
[45] R. Eisenberg. Why can't we find a new treatment for SLE? , 2009, Journal of autoimmunity.
[46] C. Langefeld,et al. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies , 2009, Nature Reviews Genetics.
[47] M. DePamphilis,et al. Contributions of the two accessory subunits, RNASEH2B and RNASEH2C, to the activity and properties of the human RNase H2 complex , 2008, Nucleic acids research.
[48] T. Heidmann,et al. Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity , 2008, Cell.
[49] S. Nagata. Autoimmune diseases caused by defects in clearing dead cells and nuclei expelled from erythroid precursors , 2007, Immunological reviews.
[50] D. Barnes,et al. Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease , 2007, Cell.
[51] S. Nelson,et al. C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy , 2007, Nature Genetics.
[52] J. Lieberman,et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus , 2007, Nature Genetics.
[53] J. Lieberman,et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus , 2007, Journal of Molecular Medicine.
[54] D. Barnes,et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. , 2007, American journal of human genetics.
[55] T. Vyse,et al. General aspects of the genetics of SLE , 2007, Autoimmunity.
[56] C. Kallenberg,et al. Ultraviolet light and cutaneous lupus , 2006, Lupus.
[57] J. Harley,et al. The curiously suspicious: a role for Epstein-Barr virus in lupus , 2006, Lupus.
[58] A. Marshak‐Rothstein. Toll-like receptors in systemic autoimmune disease , 2006, Nature Reviews Immunology.
[59] Annalisa Ballarini,et al. Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p. , 2006, American journal of human genetics.
[60] C. Ponting,et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection , 2006, Nature Genetics.
[61] D. Barnes,et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus , 2006, Nature Genetics.
[62] J. Lieberman,et al. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. , 2006, Molecular cell.
[63] H. Cook,et al. Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus , 2006, Nature Clinical Practice Rheumatology.
[64] J. Satia,et al. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden , 2006, Lupus.
[65] J. Reveille,et al. Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis. , 2004, Arthritis and rheumatism.
[66] D. Barnes,et al. Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis , 2004, Molecular and Cellular Biology.
[67] L. Rönnblom,et al. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. , 2004, Arthritis and rheumatism.
[68] Francis Harper,et al. Identification of autonomous IAP LTR retrotransposons mobile in mammalian cells , 2004, Nature Genetics.
[69] J. V. Moran,et al. Mobile elements and mammalian genome evolution. , 2003, Current opinion in genetics & development.
[70] G. Karypis,et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[71] M. Shlomchik,et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.
[72] M. Shlomchik,et al. From T to B and back again: positive feedback in systemic autoimmune disease , 2001, Nature Reviews Immunology.
[73] T. Horiuchi,et al. Mutation of DNASE1 in people with systemic lupus erythematosus , 2001, Nature Genetics.
[74] K. Nishikura,et al. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. , 2000, Science.
[75] T. Möröy,et al. Features of systemic lupus erythematosus in Dnase1-deficient mice , 2000, Nature Genetics.
[76] Dan J. Mazur,et al. Identification and Expression of the TREX1 and TREX2 cDNA Sequences Encoding Mammalian 3′→5′ Exonucleases* , 1999, The Journal of Biological Chemistry.
[77] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[78] J. Tolmie,et al. The Aicardi-Goutières syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis). , 1995, Journal of medical genetics.
[79] C. Mathews,et al. Natural DNA Precursor Pool Asymmetry and Base Sequence Context as Determinants of Replication Fidelity (*) , 1995, The Journal of Biological Chemistry.
[80] J. Aicardi,et al. Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy , 1988, Journal of the Neurological Sciences.
[81] J. Aicardi,et al. A Progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis , 1984, Annals of neurology.
[82] J F Fries,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.
[83] J. Lieberman,et al. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1 , 2010 .
[84] K. Nishikura,et al. A new function for the RNA-editing enzyme ADAR1 , 2009, Nature Immunology.
[85] L. Pasquier,et al. Orphanet Journal of Rare Diseases , 2006 .
[86] W. Riley. Autoimmune polyglandular syndromes. , 1992, Hormone research.